Icon Plc ICLR shares are crashing in Thursday’s premarket session as the company disclosed an update on its upcoming earnings report. The clinical research organisation disclosed an ongoing internal ...

ICON plc, (NASDAQ: ICLR) today announced that it intends to release its fourth quarter and full year 2025 earnings results on or prior to April 30, 2026. The Company also announced an ongoing internal ...

Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of ICON plc (NASDAQ: ICLR) resulting from allegations that ...

ICON plc (NASDAQ: ICLR) today announced a significant expansion of oncology research capabilities within its Accellacare Site Network through the opening of the Brian Moran Cancer Institute at Duly ...

Orbis Investment Management released its Q4 2025 investor letter for “Orbis SICAV International Equity Fund”. The Strategy reported a positive year in 2025, with returns driven more by stock-specific ...

Investing.com -- ICON plc (NASDAQ:ICLR) stock plummeted 32% on Thursday after the clinical research organization announced an internal accounting investigation and delayed its fourth quarter and full ...

We recently published 10 Market Beasts Leaving Wall Street in the Dust. ICON PLC (NASDAQ:ICLR) was one of the best performers on Friday. ICON grew its share prices by 16.13 percent on Friday to finish ...

ICON plc is a world-leading clinical research organisation powered by healthcare intelligence. From molecule to medicine, we advance clinical research providing outsourced services to pharmaceutical, ...

Icon PLC (ICLR) came out with quarterly earnings of $2.63 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $1.90 per share a year ago. These figures are adjusted for ...

Have you been searching for a stock that might be well-positioned to maintain its earnings-beat streak in its upcoming report? It is worth considering Icon PLC (ICLR), which belongs to the Zacks ...

DUBLIN--(BUSINESS WIRE)--ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today announced that Dr. Steve Cutler, CEO of ICON plc, will ...